CORRESP Filing
Hinge Health, Inc.
Date: May 19, 2025 · CIK: 0001673743 · Accession: 0001193125-25-122330
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285682
Letter
Re: Hinge Health, Inc. Registration Statement on Form S-1, as amended (File No. 333-285682) Request for Acceleration of Effective Date Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended (the “ Act ”), we, as representatives of the several underwriters, hereby join in the request of Hinge Health, Inc. (the “ Company ”) for acceleration of the effective date of the above-referenced Registration Statement on Form S-1 so that it becomes effective as of 4:00 p.m. Eastern time on May 21, 2025, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Latham & Watkins LLP, request by telephone to the staff of the Securities and Exchange Commission that such Registration Statement be declared effective. Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 BofA Securities, Inc. One Bryant Park New York, New York 10036 May 19, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010
Attn: Ryan Rohn Stephen Krikorian Mariam Mansaray Jan Woo
We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours,
Morgan Stanley & Co. LLC Barclays Capital Inc.
BofA Securities, Inc.
As representatives of the several Underwriters listed in Schedule
II of the Underwriting Agreement
By:
Show Raw Text
CORRESP 1 filename1.htm CORRESP Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 BofA Securities, Inc. One Bryant Park New York, New York 10036 May 19, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Attn: Ryan Rohn Stephen Krikorian Mariam Mansaray Jan Woo Re: Hinge Health, Inc. Registration Statement on Form S-1, as amended (File No. 333-285682) Request for Acceleration of Effective Date Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended (the “ Act ”), we, as representatives of the several underwriters, hereby join in the request of Hinge Health, Inc. (the “ Company ”) for acceleration of the effective date of the above-referenced Registration Statement on Form S-1 so that it becomes effective as of 4:00 p.m. Eastern time on May 21, 2025, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Latham & Watkins LLP, request by telephone to the staff of the Securities and Exchange Commission that such Registration Statement be declared effective. Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus. We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. 2 Very truly yours, Morgan Stanley & Co. LLC Barclays Capital Inc. BofA Securities, Inc. As representatives of the several Underwriters listed in Schedule II of the Underwriting Agreement By: Morgan Stanley & Co. LLC By: /s/ Eleni Apostolatos Name: Eleni Apostolatos Title: Vice President By: Barclays Capital Inc. By: /s/ Jamie Turturici Name: Jamie Turturici Title: Managing Director, Head of Technology Equity Capital Markets By: BofA Securities, Inc. By: /s/ AnnaMaria Freeman Name: AnnaMaria Freeman Title: Director [ Signature Page to Underwriters’ Acceleration Request ]